3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.


Andheri East, Mumbai - 400099, India.


All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00



Andheri East

Mumbai – 400099, India.

Bortezomib Injection

  • antineoplastic agent
  • modified dipeptidyl boronic acid


Bortezomib for Injection is an antineoplastic agent available for intravenous injection or subcutaneous use. It is used in the treatment of Multiple Myeloma and Mantle Cell Lymphoma . Each vial contains  bortezomib as a sterile lyophilized powder and inactive ingredient.

Bortezomib is a modified dipeptidyl boronic acid. The product is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid. The drug substance exists in its cyclic anhydride form as a trimeric boroxine. It comes in two dosage i.e. 2 mg & 3.5 mg. It has to be stored at 2-8 degree celsius and comes in powder form with solvent.

It is manufactured by many Indian manufacturers like Jannsen, Celon Labs, Natco Pharma etc. 3s corporation is supplier,Exporter  for Bortezomib for Injection in India. It is popularly known as Velcade in Europe and America.

Additional Information

Reconstitute with 3.5 mL of 0.9% Sodium Chloride resulting in a final concentration of 1 mg/mL of bortezomib. The reconstituted product should be a clear and colorless solution.

Reconstituted solution should be administered within 8 hours of preparation.

Side Effects

  • hives
  • difficulty breathing
  • swelling of your face, lips, tongue, or throat.
  • Bortezomib may cause a serious viral infection of the brain that can lead to disability or death

Pack Size